Skip Main Navigation
Page Content

Save This Event

Event Saved

Investor Spotlight: The Dementia Discovery Fund

JLABS @ Toronto

Thursday, March 15, 2018 from 10:30 AM to 1:00 PM (EDT)

Investor Spotlight: The Dementia Discovery Fund

Ticket Information

Ticket Type Sales End Price * Fee Quantity
Presentation & Lunch   more info Mar 14, 2018 CA$15.00 CA$1.90
Media/Press   more info Mar 7, 2018 Free CA$0.00
Volunteer   more info Mar 7, 2018 Free CA$0.00
* Prices include GST/HST

Share Investor Spotlight: The Dementia Discovery Fund

Event Details

Let's get more solutions to patients. The Johnson & Johnson Innovation, JLABS (JLABS) Meet with… Series helps life sciences entrepreneurs, as well as the academic community, connect with potential partners including corporate venture, VC's, Angels and other investment entities.

On March 15th, Barbara Tate, Venture Partner at Dementia Discovery Fund will be in attendance to give an overview presentation about their company's key areas of interest and to meet 1-on-1 with companies that have been accepted after applying online.

*Companies must have applied for a one-on-one meeting ahead of time and been approved. Applications are due February 28th, 2018. Apply Here.

Program Overview:
The Dementia Discovery Fund (“DDF”) is a highly innovative new fund backed by the UK Government, Alzheimer’s Research UK and seven of the world’s leading pharmaceutical and biotech companies. The DDF is funding the discovery and development of new disease-modifying treatments for Alzheimer’s and other forms of dementia with the intent to dramatically improve the quality of life for the growing number of dementia sufferers and their families.

Following the presentation, don't miss this opportunity to introduce yourself to Barbara during the networking lunch. And finally, for those companies who apply online and are approved, one-on-one meetings with the Dementia Discovery Fund will provide an intimate forum to discuss your company.

Agenda:
10:30 AM | Registration and Networking
11:00 AM | Presentation and Q&A
12:00 PM | Networking and Lunch
12:30 PM - 5:00 PM | One-on-one Meetings*

*Companies must have applied for a one-on-one meeting ahead of time and be approved. The application period ends on February 28th, 2018.

Fees:
$15 | General Public
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Pre-registration to attend the presentation, Q&A, and lunch will remain open until noon on March 14th (or sold out).

Location:
JLABS @ Toronto
661 University Ave, Suite 1300
Toronto, Ontario

Event Partner:



Dementia Discovery Fund Representative:
Barbara Tate, Ph.D | Venture Partner, Dementia Discovery Fund
Dr. Barbara Tate is a neuroscientist who has worked in both large and small pharmaceutical companies. Prior to joining DDF, she was Vice President and Head of Biology at Rodin Therapeutics, an Atlas Venture company, where she also consulted on other portfolio companies. Prior to Rodin, Barbara was Vice President for Research at Satori Pharmaceuticals, a biotech company developing a treatment for Alzheimer’s disease. Barbara also worked at Pfizer, where she managed the neurodegenerative disease area group in Groton, CT.

Prior to working in industry, Barbara was an academic researcher at Brown Medical School and Harvard Medical School. Barbara has a BA in Biology, a PhD in Physiology, and she was a postdoctoral fellow at Harvard Medical School. The Dementia Discovery Fund (“DDF”) is a highly innovative new fund backed by the UK Government, Alzheimer’s Research UK and seven of the world’s leading pharmaceutical and biotech companies. The DDF is funding the discovery and development of new disease-modifying treatments for Alzheimer’s and other forms of dementia with the intent to dramatically improve the quality of life for the growing number of dementia sufferers and their families.
Connect with Barbara:   Connect on LinkedIn

Have questions about Investor Spotlight: The Dementia Discovery Fund? Contact JLABS @ Toronto

Save This Event

Event Saved

When & Where


JLABS @ Toronto
661 University Ave
Suite 1300
Toronto, ON M5G 1M1
Canada

Thursday, March 15, 2018 from 10:30 AM to 1:00 PM (EDT)


  Add to my calendar

Organizer

JLABS @ Toronto

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow. At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries. JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property. JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then has grown to eight locations including the Bay Area, Boston & Lowell, MA, Houston, Toronto and a ninth location, New York City, launching in 2018. For more information please visit jlabs.jnjinnovation.com.

  Contact the Organizer
Investor Spotlight: The Dementia Discovery Fund
Things to do in Toronto Networking Business

Please log in or sign up

In order to purchase these tickets in installments, you'll need an Eventbrite account. Log in or sign up for a free account to continue.